NTQ5082 capsules
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NTQ5082 capsules, covering 2025-09-17 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients [Phase 2]